[Dendritic cell-based cancer vaccine].
The varieties of treatments for patients with cancer have increased rapidly during the last few years. One of the newer ways to treat cancer patients is by immune therapy using tumor antigen pulsed dendritic cell-based vaccination. Phase I and II trials have shown effectiveness in generating an immunologic response and have in some cases shown clinical responses with tumour regression. This paper describes some of the possibilities and perspectives for dendritic cell vaccines for cancer patients.
Burgdorf
Stefan K
SK
Amtssygehuset i Gentofte, Kirurgisk Gastroenterologisk Afdeling D, Hellerup. stebur01@gentoftehosp.kbhamt.dk
Claësson
Mogens H
MH
Rosenberg
Jacob
J
D000951:Antigens, Neoplasm / Q000276:immunology; D019496:Cancer Vaccines / Q000276:immunology / Q000627:therapeutic use*; D003713:Dendritic Cells / Q000276:immunology; D006801:Humans; D008213:Lymphocyte Activation; D013601:T-Lymphocytes / Q000276:immunology
D000951:Antigens, Neoplasm; D019496:Cancer Vaccines